The Journal of Allergy and Clinical Immunology 2002: Vol 109 Index

39 Pages·2002·10.9 MB·English

Index to volume 109
Author index*
A Aoki M (see Watanabe et al). 2002;109:669-75
Abbal M (see Rancé et al). 2002;109:1027-33 Arikita H (see Shiota et al). 2002;109:294-8
Adachi M (see Tanaka et al). 2002;109:485-90 Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao
Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. X-Q, Enomoto T, Dake Y, Shimazu S-I, Yamashita T,
Intranasal steroids and the risk of emergency depart- Sugawara N, Brodeur S, Geha R, Puri RK, Sayegh MH,
ment visits for asthma. 2002;109:636-42 Adra CN, Hamasaki N, Hopkin JM, Shirakawa T,
Adcock IM (see Irusen et al). 2002;109:649-57 Izuhara K. Upregulation of IL-13 concentration in vivo
Adkinson NF Jr, Essayan D, Gruchalla R, Haggerty H, by the /L/3 variant associated with bronchial asthma.
Kawabata T, Sandler JD, Updyke L, Shear NH, Wierda 2002; 109:980-7
D. Task force report: future research needs for the pre- Aromaa A (see Karjalainen et al). 2002;109:514-6
vention and management of immune-mediated drug (Brief communication)
hypersensitivity reactions. 2002;109:S461-S478 Arrighi J-F (see Zarei et al). 2002;109:988-94
Adra CN (see Arima et al). 2002;109:980-7 Arvidsson MB, Léwhagen O, Rak S. Effect of 2-year
Afferni C (see Tinghino et al). 2002;109:314-20 placebo-controlled immunotherapy on airway symp-
Aharoni D (see Confino-Cohen et al). 2002;109:349-56 toms and medication in patients with birch pollen allergy.
Ahlstedt S (see Lin et al). 2002;109:879-87 2002; 109:777-83
Aizawa H, Plitt J, Bochner BS. Human eosinophils express Asero R, Mistrello G, Roncarolo D, Amato S. A case of
two Siglec-8 splice variants. 2002;109:176 allergy to airborne, heat-labile shrimp allergens.
(Letters to the editor) 2002;109:371-2 (Letters to the editor)
Akaiwa M (see Arima et al). 2002;109:980-7 Assa’ad AH (see Kudva-Patel et al). 2002;109:888-9
Akdis CA (see Trautmann et al). 2002;109:329-37 (Letters to the editor)
Akdis M (see Trautmann et al). 2002;109:329-37 Atkins KM (see Birnbaum et al). 2002;109:264-70
Akin C (see Brockow et al). 2002;109:82-8 Atkinson TP (see Hoek et al). 2002;109:470-6
Akiyama K (see Kawagishi et al). 2002;109:936-42 Auerbach R (see Birnbaum et al}. 2002;109:264-70
Akkaya A (see Trautmann et al). 2002;109:329-37
Aksoy MO, Mardini IA, Yang Y, Bin W, Zhou S, Kelsen B
SG. Glucocorticoid effects on the B-adrenergic recep- Bablitz B (see Logan et al). 2002;109:299-306
tor-adenylyl cyclase system of human airway epitheli- Bacellar O (see Carvalho et al). 2002;109:102-5
um. 2002;109:491-7 Bacharier LB. “Step-down” therapy for asthma: why,
Alamar R (see Basomba et al). 2002;109:943-8 when, and how? 2002;109:916-9 (Editorial)
Alenius H, Laouini D, Woodward A, Mizoguchi E, Bhan Bachert C, Lukat K-F, Lange B. Short-term use of
AK, Castigli E, Oettgen HC, Geha RS. Mast cells regu- intranasal corticosteroids: lack of systemic effects.
late INF-y expression in the skin and circulating IgE 2002; 109:573-4 (Letters to the editor)
levels in allergen-induced skin inflammation. Baker JR Jr (see Fritz et al). 2002;109:214-28 (Rostrum)
2002: 109: 106-13 Bal V (see Bhatia et al). 2002;109:321-8
Alghadeer H (see Saary et al). 2002;109:131-5 Ballmer-Weber BK (see Pastorello et al). 2002;109:563-70
Allen BR. Tacrolimus ointment: its place in the therapy of Ballow M. Primary immunodeficiency disorders: antibody
atopic dermatitis. 2002;109:401-3 (Editorial) deficiency. 2002;109:581-91
Alvarez J (see Posadas et al). 2002;109:155-61 Bandeira-Melo C, Bozza PT, Weller PF. The cellular biolo-
Amato S (see Asero et al). 2002;109:371-2 gy of eosinophil eicosanoid formation and function.
(Letters to the editor) 2002; 109:393-400
Anderson AJ (see Baramki et al). 2002;109:449-54 Bandeira-Melo C, Hall JC, Penrose JF, Weller PF. Cys-
Anderson SD, Brannan JD. Exercise induced asthma: is there teiny! leukotrienes induce IL-4 release from cord
still a case for histamine. 2002;109:771-3 (Editorial) blood-derived human eosinophils. 2002;109:975-9
Anney RJL (see Elliott et al). 2002;109:176-8 Bannon GA (see Helm et al). 2002;109:136-42
(Letters to the editor) Baraldi E (see Zanconato et al). 2002;109:440-5
Ansaloni R (see Pastorello et al). 2002;109:563-70 Baramki D, Koester J, Anderson AJ, Borish L. Modulation
Anstrén G (see Dahlén et al). 2002;109:789-93 of T-cell function by (R)-and (S)-isomers of albuterol:
anti-inflammatory influences of (R)-isomers are negat-
ed in the presence of the (S)-isomer. 2002; 109:449-54
Barat E (see Vizi et al). 2002;109:446-8
*January, part |, pp. 1-186 and S1-S20; part 2, pp. S21-S446; February, part
(Brief communication)
1, pp. 187-376; part 2, pp. S447-S460; March, pp. 377-578 and S461-
$478; April, pp. 579-744; May, pp. 745-892; June, pp. 893-1080 Barbee RA (see Guerra et al). 2002;109:419-25
1044 Author index J ALLERGY CLIN IMMUNOL
JUNE 2002
Barberio G (see Pajno et al). 2002:109:627-9 Blanca M (see Posadas et al). 2002;109:155-61
(Brief communication) Blanco C (see Charous et al). 2002:109:31-4 (Rostrum)
Barletta B (see Tinghino et al). 2002;109:314-20 Blaschke V (see Reich et al). 2002:109:618- 7
Barnes PJ (see Hansel et al). 2002;109:575 (Correspondence) Blaser K (see Trautmann et al). 2002; 109:329-37
Barnes PJ (see Irusen et al). 2002;109:649-57 Bleecker ER (see Koppelman et al). 2002;109:498-506
Barnes PJ (see Montuschi and Barnes). 2002:109:615-20 Block SH. Chronic sinusitis with rofecoxib. 2002:109:373
Basomba A, Tabar Al, de Rojas DHF, Garcia BE, Alamar (Correspondence)
R, Olaguibel JM, del Prado JM, Martin S, Rico P. Aller- Blémeke B (see Sieben et al). 2002:109: 1005-11
gen vaccination with a liposome-encapsulated extract of Bochenek G (see Szczeklik et al). 2002:109:572-3
Dermatophagoides pteronyssinus: a randomized, dou- (Letters to the editor)
ble-blind, placebo-controlled trial in asthmatic patients Bochner BS (see Aizawa et al). 2002:109:176
2002: 109:943-8 (Letters to the editor)
Bastl-Borrmann R (see Zuberbier et al). 2002:109:343-8 Bock A (see Taylor et al). 2002;109:24-30 (Rostrum)
Basu SK (see Bhatia et al). 2002:109:321-8 Boltz-Nitulescu G (see Untersmayr et al). 2002:109:1034-5
Battucci S (see Sercombe et al). 2002:109:716-7 (Letters to the editor)
(Letters to the editor) Borish L (see Baramki et al). 2002:109:449-54
Baur X (see Charous et al). 2002:109:31-4 (Rostrum) Borish L. Sinusitis and asthma: entering the realm of evi-
Beasley R. The burden of asthma with specific reference to dence-based medicine. 2002:109:606-8 (Editorial)
the United States. 2002;109:S482-S489 Boschetto P (see Mapp et al). 2002;109:867-72
Beausoleil JL (see Spergel et al). 2002:109:363-8 Bész6rményi-Nagy G (see Vizi et al). 2002:109:446-8
Becker AB. Challenges to treatment goals and outcomes in (Brief communication)
pediatric asthma. 2002: 109:S533-S538 Bottomly K (see Herrick et al). 2002;109:873-8
Beezhold D (see Charous et al). 2002:109:31-4 (Rostrum) Boulay M-(E with backward accent) (see Davoine et al)
Behrendt H (see Traidl-Hoffmann et al). 2002: 109:831-8 2002:109:463-9
Bel EH (see ten Brinke et al). 2002:109:621-6 Boushey HA (see Szefler et al). 2002:109:410-8 (Rapid
Bender BG. Overcoming barriers to nonadherence in asth publications)
ma treatment. 2002:109:S554-S559 Boushey HA, Stempel DA. Foreword. 2002:109:S479-S48 1
Bengtsson U (see Lin et al). 2002:109:879-87 Bozza PT (see Bandeira-Melo et al). 2002: 109:393-400
Benitez P (see Mullol et al). 2002:109:824-30 Brambilla C (see Devouassoux et al). 2002:109:847-53
Benkov K (see Beyer et al). 2002;109:707-13
Brannan JD (see Anderson and Brannan). 2002:109:771-3
Benno Y (see He et al). 2002:109: 1035-6 (Editorial)
Letters to the editor) Brattsand R (see Yamada et al). 2002:109:35-42
Berger WE (see Birnbaum et al). 2002;109:264-70 (Rapid publications)
Bergmann K-C (see Kuehr et al). 2002:109:274-80 Brauburger J (see Kuehr et al). 2002:109:274-80
Berth-Jones J (see Reitamo et al). 2002:109:547-55 Breuer K (see Wedi et al). 2002:109:477-84
Beyer K (see Kircher et al). 2002:109:517-2 Britton J (see Broadfield et al). 2002;109:969-74
Beyer K, Castro R, Birnbaum A, Benkov K, Pittman N, Broadfield E, McKeever TM, Scrivener S, Venn A, Lewis
Sampson HA. Human milk—specific mucosal lympho- SA, Britton J. Increase in the prevalence of allergen skin
cytes of the gastrointestinal tract display a T,,2 cytokine sensitization in successive birth cohorts. 2002: 109:969-74
profile. 2002;109:707-13 Brécker E-B (see Trautmann et al). 2002;109:329-37
Beyer K, Castro R, Feidel C, Sampson HA. Milk-induced Brockow K, Akin C, Huber M, Scott LM, Schwartz LB;
urticaria is associated with the expansion of T cells Metcalfe DD. Levels of mast-cell growth factors in
expressing cutaneous lymphocyte antigen plasma and in suction skin blister fluid in adults with
2002: 109:688-93 mastocytosis: correlation with dermal mast-cell num-
Khan AK (see Alenius et al). 2002; 109: 106-13 bers and mast-cell tryptase. 2002:109:82-8
Bhatia S,M ukhopadhyay S, Jarman E, Hall G, George A Brodeur S (see Arima et al). 2002: 109:980-7
Basu SK, Rath S, Lamb JR, Bal \ Scavengel recep Brouwer J-LP (see Oude Elberink et al). 2002:109: 162-70
tor—specific allergen delivery elicits IFN-y-dominated Brown DD (see Weiler et al). 2002;109:995-1000
immunity and directs established T,,2-dominated Brown LK (see Sercombe et al). 2002;109:716-7
responses to a nonallergic phenotype. 2002;109:322 1-8 (Letters to the editor)
Bieber T (see Reitamo et al). 2002;109:547-55 Bruijnzeel-Koomen CAFM (see Schade et al)
Bin W (see Aksoy et al). 2002:109:49] 2002-109:357-62
Bindslev-Jensen ¢ ver Taylor et al). 2002:109:24-30 (Ros Briining T (see Raulf-Heimsoth et al). 2002:109:715-6
trum) (Letters to the editor)
Birnbaum A (see Beyer et al). 2002;109:707-13 Brutsche MH, Joos L, Carlen Brutsche IEA, Bissinger R,
Birnbaum HG, Berger WE, Greenberg PE, Holland M, Tamm M, Custovic A, Woodcock A. Array-based diag-
Auerbach R, Atkins KM, Wanke LA. Direct and indi nostic gene-expression score for atopy and asthma
rect costs of asthma to an employer. 2002:109:264-70 2002: 109:271-3
Bissinger R (see Brutsche et al). 2002;109:271-3 Buchs A (see Confino-Cohen et al). 2002:109:349-56
J ALLERGY CLIN IMMUNOL Author index 1045
VOLUME 107, NUMBER 6
Buckley RH. Primary cellular immunodeficiencies Clouse J. Establishing value in managed care: cost-effec-
2002: 109:747-57 tiveness or budgetary impact? 2002;109:S511-S513
Bukantz SC. Clemens von Pirquet and the concept of Cockrell G (see Helm et al). 2002;109: 136-42
allergie. 2002;109:724-6 (The allergy archives) Cohen S. Francis M. Rackemann. 2002:;109:179-80
Burks AW (see Helm et al). 2002;109:136-42 (The allergy archives)
Burks AW Jr (see Taylor et al). 2002;109:24-30 (Rostrum) Cohen SG. Clemens von Pirquet, MD (1874-1929).
Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of 2002; '09:722-4 (The allergy archives)
intravenous immunoglobulin in the prevention of pneu- Collins J (see McKeever et al). 2002;109:43-50
monia in patients with common variable immunodefi- (Rapid publications)
ciency. 2002;109: 1001-4 Collins MH (see Kudva-Patel et al). 2002; 109:888-9
Butler WK (see Tankersley et al). 2002; 109:556-62 (Letters to the editor)
Butteroni C (see Tinghino et al). 2002:109:314-20 Colomb MG (see Devouassoux et al). 2002:109:847-53
Confino-Cohen R, Aharoni D, Goldberg A, Gurevitch I,
Cc Buchs A, Weiss M, Weissgarten J, Rapoport MJ. Evi
Calamari M (see Pastorello et al). 2002:109:563-70 dence for aberrant regulation of the p21 Ras pathway in
Cambazard F (see Reitamo et al). 2002; 109:547-55, 539-46 PBMCs of patients with chronic idiopathic urticaria.
Camp R (see Shah et al). 2002;109:1012-8 2002; 109:349-56
Canonica GW (see Pajno et al). 2002;:109:627-9 Connaughton C (see Helm et al). 2002;109: 136-42
(Brief communication) Conti A (see Pastorello et al). 2002;109:563-70
Carlen Brutsche IEA (see Brutsche et al). 2002:109:271-3 Cooper D (see Shah et al). 2002;109:1012-8
Carvalho EM (see Carvalho et al). 2002;109:102-5 Corrigan C (see Hawrylowicz et al). 2002;109:369
Carvalho LP, Bacellar O, Neves N, de Jesus AR, Carvalho (Letters to the editor)
EM. Downregulation of IFN-y production in patients Counts JL (see Sercombe et al). 2002:109:716-7
with recurrent vaginal candidiasis. 2002;109:102-5 (Letters to the editor)
Casolaro V (see Schroeder et al). 2002;109:507-13 Covar R (see Spahn et al). 2002;109:S490-S502
Casolaro V (see Valapour et al). 2002;109:238-45 Craig TJ (see Szefler et al). 2002:109:410-8
(Rapid publications) (Rapid publications)
Cassell GH (see Hoek et al). 2002:109:470-6 Crameri R (see Trautmann et al). 2002; 109:329-37
Castigli E (see Alenius et al). 2002:109:106-13 Cron SG (see Shearer et al). 2002;109:854-7
Castro R (see Beyer et al). 2002; 109:688-93, 707-13 (Brief communication)
Chakir J (see Davoine et al). 2002:109:463-9 Crown WH (see Crystal-Peters et al). 2002;109:57-62
Charous BL, Blanco C, Tarlo S, Hamilton RG, Baur X, Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treat-
Beezhold D, Sussman G, Yunginger JW. Natural rubber ing allergic rhinitis in patients with comorbid asthma:
latex allergy after 12 years: recommendations and per the risk of asthma-related hospitalizations and emer-
spectives. 2002:109:31-4 (Rostrum) gency department visits. 2002;109:57-62
Cherniack RM (see Szefler et al). 2002:109:410-8 Csoma Z (see Vizi et al). 2002;109:446-8
(Rapid publications) (Brief communication)
Chinchilli VM (see Szefler et al). 2002:109:410-8 Cunningham-Rundles C (see Busse et al). 2002;109: 1001-4
(Rapid publications) Currie GP (see Fowler\ et al). 2002;109:929-35
Cho S-H (see Kim et al). 2002:109:630-5 Custovic A (see Brutsche et al). 2002;109:271-3
Choi IS (see Koh et al). 2002:109:714-5
(Letters to the editor) D
Chowdhury BA, Meyer RJ. Intramuscular versus subcuta- Dahlén B, Roquet A, Inman MD, Karlsson O, Naya I,
neous injection of epinephrine in the treatment of ana- Anstrén G, O’Byrne PM, Dahlén S-E. Influence of
phylaxis. 2002:109:720 (Correspondence) zafirlukast and loratadine on exercise-induced bron-
Christie L (see Taylor et al). 2002:109:24-30 (Rostrum) choconstriction. 2002; 109:789-93
Chrousos GP (see Kino and Chrousos). 2002;109:609-13 Dahlén S-E (see Dahlén et al). 2002;109:789-93
Chung HL, Hwang JB, Park JJ, Kim SG. Expression of DahIman-Hoéglund A (see Lin et al). 2002;109:879-87
transforming growth factor $1, transforming growth Dake Y (see Arima et al). 2002;109:980-7
factor type I and II receptors, and TNF-o in the mucosa Das J (see Herrick et al). 2002 109:873-8
of the small intestine in infants with food protein Davies DE (see Polosa et al). 2002;109:75-81
induced enterocolitis syndrome. 2002; 109: 150-4 Davoine F, Lavigne S, Chakir J, Ferland C, Boulay M-(E
Chung KF (see Irusen et al). 2002; 109:649-57 with backward accent), Laviolette M. Expression of
Churg A (see Lilly et al). 2002:109:S1-S19 FeyRIII (CD16) on human peripheral blood eosinophils
Cianferoni A (see Schroeder et al). 2002;109:507-13 increases in allergic conditions. 2002;109:463-9
Cianferoni A (see Valapour et al). 2002; 109:238-45 de Bruine FT (see ten Brinke et al). 2002;109:621-6
(Rapid publications) de Jesus AR (see Carvalho et al). 2002:109:102-5
Claman HN. Glucocorticoids in herbal formulas? De Marzo N (see Mapp et al). 2002;109:867-72
2002:109:1038 (Correspondence) de Monchy JGR (see Oude Elberink et al). 2002; 109: 162-70
1046 Author index J ALLERGY CLIN IMMUNOL
JUNE 2002
de Prost Y (see Reitamo et al). 2002;109:539-46 Fahy JV (see Szefler et al). 2002;109:410-8
de Rojas DHF (see Basomba et al). 2002;109:943-8 (Rapid publications)
del Prado JM (see Basomba et al). 2002; 109:943-8 Falci K (see Vierk et al). 2002:109:1022-6
Delwiche J-P (see Vandenplas et al). 2002;109: 125-30 Farioli L (see Pastorello et al). 2002; 109:563-70
Dempsey OJ, Kennedy G, Lipworth BJ. Comparative efficacy Feidel C (see Beyer et al). 2002;109:688-93
and anti-inflammatory profile of once-daily therapy with Ferdousi HA (see MOller et al). 2002;109:251-6
leukotriene antagonist or low-dose inhaled corticosteroid Ferland C (see Davoine et al). 2002;109:463-9
in patients with mild persistent asthma. 2002; 109:68-74 Fernandez-Morata JC (see Mullol et al). 2002;109:824-30
Denburg JA (see Upham et al). 2002;109:307-13 Fernandez-Nieto M (see Quirce et al). 2002;109:178
Devouassoux G (see Foster et al). 2002;109:287-93 (Letters to the editor)
Devouassoux G, Saxon A, Metcalfe DD, Prussin C, Colomb Ferrari D (see Idzko et al). 2002;109:839-46
MG, Brambilla C, Diaz-Sanchez D. Chemical constituents Feussner I (see Traidl-Hoffmann et al). 2002;109:831-8
of diesel exhaust particles induce IL-4 production and hist- Finkelman FD (see Strait et al). 2002; 109:658-68
amine release by human basophils. 2002; 109:847-53 Finkelstein JA (see Adams et al). 2002;109:636-42
Di Felice G (see Tinghino et al). 2002;109:314-20 Fish JE (see Szefler et al). 2002;109:410-8
Di Virgilio F (see Idzko et al). 2002;109:839-46 (Rapid publications)
Diaper ND (see Jones et al). 2002; 109:858-66 Fitzpatrick EB (see Elliott et al). 2002;109:176-8
Diaz-Sanchez D (see Devouassoux et al). 2002;109:847-53 (Letters to the editor)
Dichmann § (see Idzko et al). 2002;109:839-46 Flagan RC (see Taylor et al). 2002;109:51-6
Diepgen TL (see Reitamo et al). 2002; 109:547-55 Focke M (see Tinghino et al). 2002;109:314-20
Djukanovic R. Airway inflammation in asthma and its con- Focke M (see Untersmayr et al). 2002:109: 1034-5
sequences: implications for treatment in children and (Letters to the editor)
adults. 2002;109:S539-S548 Ford JG (see Strunk et al). 2002;109:229-37
Dolovich M (see Szefler et al). 2002;109:410-8 Ford JG (see Szefler et al). 2002:109:410-8
(Rapid publications) (Rapid publications)
Drazen JM (see Szefler et al). 2002;109:410-8 Forrest SM (see Elliott et al). 2002;109:176-8
(Rapid publications) (Letters to the editor)
Dreborg S (see Moller et al). 2002;109:251-6 Fortunato D (see Pastorello et al). 2002; 109:563-70
Druey KM (see Johnson and Druey). 2002;109:592-602 Foster B, Schwartz LB, Devouassoux G, Metcalfe DD,
Dubois AEJ (see Oude Elberink et al). 2002;109:162-70 Prussin C. Characterization of mast-cell tryptase—
Duez C (see Tomkinson et al). 2002;109:810-6 expressing peripheral blood cells as basophils.
Duffy LB (see Hoek et al). 2002;109:470-6 2002; 109:287-93
Fowler SJ, Currie GP, Lipworth BJ. Step-down therapy
E with low-dose fluticasone-salmeterol combination or
Ebner S (see Reider et al). 2002;109:89-95 medium-dose hydrofluoroalkane | 34a-beclomethasone
Edsbacker S (see O’ Dowd et al). 2002;109: 1037 alone. 2002;109:929-35
(Correspondence) Freeman TM (see Tankersley et al). 2002; 109:556-62
Educ GD (see Mitakakis et al). 2002;109:122-4 Frew AJ (see Park and Frew). 2002;109:774-6 (Editorial)
(Brief communication) Frew AJ. Asthma biomarkers and drug trials
Egan RW (see Rizzo et al). 2002;109:404-9 2002; 109:210-3 (Editorial)
(Rapid publications) Friedmann PS (see Reitamo et al). 2002;109:547-55
Eggleston PA (see Phipatanakul et al). 2002;109:794-9 Frischer M (see McKeever et al). 2002;109:43-50
Figen H (see Szefler and Eigen). 2002;109:729-42 (Rapid publications)
(New products) Fritsch P (see Reider et al). 2002;109:89-95
Elliott KS, Anney RJL, Fitzpatrick EB, Williamson R, For- Fritz SB, Singer AM, Revan VB, Baker JR Jr. Bioterror-
rest SM. Conservation of CNS1 and exclusion of its ism: relevance to allergy and immunology in clinical
role in atopic eczema susceptibility. 2002; 109:176-8 practice. 2002;109:214-28 (Rostrum)
(Letters to the editor) Fryer AA (see Mapp et al). 2002;109:867-72
Elliott WM (see Yamada et al). 2002;109:35-42 Fuhlbrigge AL (see Adams et al). 2002;109:636-42
(Rapid publications) Fujii T (see likura et al). 2002;109:571-2
Enomoto T (see Arima et al). 2002;109:980-7 (Letters to the editor)
Ericson TL. Discovering asthma—or, the real value of Fujiwara T (see likura et al). 2002;109:571-2
archives. 2002;109:183-4 (The allergy archives) (Letters to the editor)
Essayan D (see Adkinson et al). 2002;109:S461-S478 Fukutomi O (see Watanabe et al). 2002;109:669-75
Evrard G (see Vandenplas et al). 2002;109:125-30 Furuta GT (see Helm et al). 2002;109: 136-42
F G
Fagan JK (see Szefler et al). 2002;109:410-8 Garcia BE (see Basomba et al). 2002:109:943-8
(Rapid publications) Gauvreau GM (see Matsumoto et al). 2002:109:281-6
J ALLERGY CLIN IMMUNOL Author index 1047
VOLUME 109, NUMBER 6
Geha R (see Arima et al). 2002;109:980-7 Hamilos DL. Chronic sinusitis with rofecoxib.
Geha RS (see Alenius et al). 2002;109: 106-13 2002; 109:373-4 (Letter reply)
Gelfand EW (see Tomkinson et al). 2002:109:810-6 Hamilton RG (see Charous et al). 2002;109:31-4
Georas SN (see Valapour et al). 2002;109:238-45 (Rostrum)
(Rapid publications) Hamilton RG (see Poulos et al). 2002;109:701-6
George A (see Bhatia et al). 2002;109:321-8 Hansel TT, Sterk PJ, Holgate ST, Barnes PJ. The trials and
Gergen PJ. Rackemann and Colmes on the clinical charac- tribulations of anti-IL-5 . . . 2002;109:575
teristics of hypersensitiveness. 2002;109: 180-3 (Correspondence)
(The allergy archives) Hansen KS (see Pastorello et al). 2002;109:563-70
Giannetti A (see Mascia et al). 2002;109:532-8 Hanson L+ (see Lin et al). 2002;109:879-87
Girolomoni G (see Idzko et al). 2002;109:839-46 HarperJ (see Reitamo et al). 2002;109:539-46
Girolomoni G (see Mascia et al). 2002;109:532-8 Harris AG (see Horak et al). 2002;109:956-61
Glovsky MM (see Taylor et al). 2002;109:51-6 Harris KE (see Reed et al). 2002;109:614
Goldberg A (see Confino-Cohen et al). 2002;109:349-56 Hashimoto H (see He et al). 2002;109:1035-6
Golden DBK (see Oude Elberink et al). 2002; 109: 162-70 (Letters to the editor)
Graham LM. Balancing safety and efficacy in the treatment Hauser C (see Zarei et al). 2002; 109:988-94
of pediatric asthma. 2002; 109:S560-S566 Haustein D (see Hoff et al). 2002;109:96-101
Grammer LC (see Reed et al). 2002;109:614 Hawrylowicz C, Richards D, Loke T-K, Corrigan C, Lee T.
Gratton D (see Reitamo et al). 2002;109:539-46 A defect in corticosteroid-induced IL-10 production in
Griive M (see Kuehr et al). 2002;109:274-80 T lymphocytes from corticosteroid-resistant asthmatic
Greenberg PE (see Birnbaum et al). 2002;109:264-70 patients. 2002;109:369 (Letters to the editor)
Greenberger PA (see Reed et al). 2002;109:614 Hayashi S (see Yamada et al). 2002;109:35-42
Greenfeder S (see Rizzo et al). 2002;109:404-9 (Rapid publications)
(Rapid publications) Hayek B (see Tinghino et al). 2002;109:314-20
Grimm V, Rakoski J, Ring J. Urticaria and angioedema Hayes LM (see Upham et al). 2002;109:307-13
induced by COX-2 inhibitors. 2002;109:370 He F, Morita H, Hashimoto H, Hosoda M, Kunisaki J-I,
(Letters to the editor) Ouwehand AC, Isolauri E, Benno Y, Salminen S.
Grootendorst DC (see ten Brinke et al). 2002;109:621-6 Intestinal Bifidobacterium species induce varying
Gruchalla R (see Adkinson et al). 2002;109:S461-S478 cytokine production. 2002; 109:1035-6
Gu X (see Simons et al). 2002;109:171-5, 720-1 (Letters to the editor)
(Letter reply) Heatlie H (see McKeever et al). 2002;109:43-50
Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis (Rapid publications)
as an independent risk factor for adult-onset asthma. Hefle SL (see Taylor et al). 2002;109:24-30 (Rostrum)
2002; 109:419-25 Heine A (see Reich et al). 2002;109:618- 7
Guo J (see Valapour et al). 2002;109:238-45 Helenius I, Rytila P, Sarna S, Lumme A, Helenius M,
(Rapid publications) Remes V, Haahtela T. Effect of continuing or finishing
Gurevitch I (see Confino-Cohen et al). 2002;109:349-56 high-level sports on airway inflammation, bronchial
Gutgesell C (see Reich et al). 2002:109:618- 7 hyperresponsiveness, and asthma: a 5-year prospective
Gutzmer R, Langer K, Lisewski M, Mommert S, Rieck- follow-up study of 42 highly trained swimmers.
born D, Kapp A, Werfel T. Expression and function of 2002: 109:962-8
histamine receptors | and 2 on human monocyte- Helenius M (see Helenius et al). 2002;109:962-8
derived dendritic cells. 2002;109:524-3 1 Helm RM, Furuta GT, Stanley JS, Ye J, Cockrell G, Con-
Guyatt GH (see Oude Elberink et al). 2002;109: 162-70 naughton C, Simpson P, Bannon GA, Burks AW. A neona-
tal swine model for peanut allergy. 2002; 109: 136-42
H Hemmingsen A (see Mapp et al). 2002;109:867-72
Haahtela T (see Helenius et al). 2002;109:962-8 Hendeles L (see Lilly et al). 2002;109:S1-S19
Haahtela T (see Rinne et al). 2002:109:426-32 Henz BM (see Zuberbier et al). 2002;109:343-8
Haahtela T (see Vartiainen et al). 2U02;109:643-8 Herjavecz I (see Vizi et al). 2002;109:446-8
Haeusler T (see Kircher et al). 2002:109:517-23 (Brief communication)
Hagan LL (see Tankersley et al). 2002;109:556-62 Herold M (see Reider et al). 2002;109:89-95
Haggerty H (see Adkinson et al). 2002;109:S461-S478 Herouy Y (see Idzko et al). 2002;109:839-46
Hales J (see Shah et al). 2002;109:1012-8 Herrick CA, Xu L, Wisnewski AV, Das J, Redlich CA, Bot-
Halken S (see MOller et al). 2002;109:251-6 tomly K. A novel mouse model of diisocyanate-induced
Hall G (see Bhatia et al). 2002;109:321-8 asthma showing allergic-type inflammation in the lung
Hall JC (see Bandeira-Melo et al). 2002;109:975-9 after inhaled antigen challenge. 2002; 109:873-8
Hamasaki N (see Arima et al). 2002:109:980-7 Hey JA (see Rizzo et al). 2002;109:404-9
Hamid Q (see Toda et al). 2002;109:246-50 (Rapid publications)
(Rapid publications) Higashi N (see Kawagishi et al). 2002; 109:936-42
Hamid QA (see Suzuki et al). 2002;109:803-9 Hill DJ (see Taylor et al). 2002;109:24-30 (Rostrum)
1048 Author index J ALLERGY CLIN IMMUNOL
JUNE 2002
Hirai K (see likura et al). 2002;109:571-2 Idzko M, la Salla A, Ferrari D, Panther E, Herouy Y, Dich-
(Letters to the editor) mann S, Mockenhaupt M, Di Virgilio F, Girolomoni G,
Hirai K (see Yoshimura et al). 2002;109:817-23 Norgauer J. Expression and function of histamine
Hirsch T (see Renz et al). 2002;109:338-42 receptors in human monocyte-derived dendritic cells.
Hiyama J (see Shiota et al). 2002; 109:294-8 2002:109:839-46
Ho V (see Reitamo et al). 2002:109:539-46 Igarashi T (see Yoshimura et al). 2002:109:817-23
Hoek KL, Cassell GH, Duffy LB, Atkinson TP. Mycoplas- likura M (see Yoshimura et al). 2002;109:817-23
ma pneumoniae—induced activation and cytokine pro- likura M, Yamaguchi M, Hirai K, Suenaga A, Fujiwara T,
duction in rodent mast cells. 2002;109:470-6 Fujii T, Taketani Y, Yamamoto K. Case report: strepto-
Hoff M,. Krail M, Kistner M, Haustein D, Vieths S. Fusar- mycin-induced anaphylactic shock during oocyte
ium culmorum causes strong degradation of pollen retrieval procedures for in vitro fertilization
allergens in extract mixtures. 2002;109:96-101 2002;109:571-2 (Letters to the editor)
Hogg JC (see Yamada et al). 2002:109:35-42 Illi S (see Renz et al). 2002;109:338-42
(Rapid publications) Inman MD (see Dahlen et al). 2002;109:789-93
Holgate ST (see Hansel et al). 2002;109:575 Inman MD (see O'Byrne et al). 2002;109:575-6 (Letter
(Correspondence) reply)
Holgate ST (see Polosa et al). 2002;109:75-81 Inoue R (see Watanabe et al). 2002:109:669-75
Holland M (see Birnbaum et al). 2002;109:264-70 lrusen E, Matthews JG, Takahashi A, Barnes PJ, Chung
Holloway JA (see Jones et al). 2002;109:858-66 KF, Adcock IM. p38 Mitogen-activated protein kinase
Holloway JW (see Jones et al). 2002:109:858-66 induced glucocorticoid receptor phosphorylation
Holness DL (see Saary et al). 2002;109:131-5 reduces its activity: role in steroid-insensitive asthma
Holzmann S (see Reider et al). 2002;109:89-95 2002: 109:649-57
Hong S-N (see Koh et al). 2002;109:714-5 Ishii A (see Yoshimura et al). 2002;109:817-23
(Letters to the editor) Isolauri E (see He et al). 2002;109: 1035-6
Hopkin JM (see Arima et al). 2002;109:980 (Letters to the editor)
Hopper N (see Leung and Hopper). 2002;109:22-3 lsolauri E (see Rautava et al). 2002:109:119-21
(Editorial) (Brief communication)
Horak F, Stiibner UP, Zieglmayer R, Harris AG. Effect of Israel E (see Szefler et al). 2002:109:410-8
desloratadine versus placebo on nasal airflow and sub (Rapid publications)
jective measures of nasal obstruction in subjects with Iwata T (see Yoshimura et al). 2002;109:817-23
grass pollen—induced allergic rhinitis in an allergen- Izuhara K (see Arima et al). 2002;109:980-7
exposure unit. 2002;109:956-61
Horita N (see Shiota et al). 2002;109:294-8 J
Horvath | (see Vizi et al). 2002: 109:446-8 Jaakkola JJK, Jaakkola N, Piipari R, Jaakkola MS. Pets,
(Brief communication) parental atopy, and asthma in adults. 2002;109:784-8
Hosoda M (see He et al). 2002:109: 1035-6 Jaakkola MS (see Jaakkola et al). 2002:109:784-8
(Letters to the editor) Jaakkola N (see Jaakkola et al). 2002:109:784-8
Host A (see Moller et al). 2002:109:251-6 Jacobsen L (see Moller et al). 2002;109:251-6
Host A (see Taylor et al). 2002; 109:24-30 (Rostrum) Jakob T (see Traidl-Hoffmann et al). 2002;109:831-8
Hourithane JO’B (see Taylor et al). 2002;109:24-30 Jamart J (see Vandenplas et al). 2002;109:125-30
(Rostrum) Jarman E (see Bhatia et al). 2002:109:321-8
Howard TD (see Koppelman et al). 2002: 109:498-506 Jensen-Jarolim E (see Untersmayr et al). 2002;109: 1034-5
Howarth PH (see Polosa et al). 2002:109:75-8 1 (Letters to the editor)
Howie K (see Upham et al). 2002;109:307-13 Jerrim KL, Whitmore LF, Hughes JF, McKechnie MT. Air-
Hubbard R (see McKeever et al). 2002; 109:43-50 borne dust and allergen generation during dusting with
(Rapid publications), 800-2 (Brief communication) and without spray polish. 2002;109:63-7
Huber M (see Brockow et al). 2002:109:82-8 Jerzynska J (see Stelmach et al). 2002:109:257-63
Huger M (see Traidl-Hoffmann et al). 2002:109:831-8 Johnson EN, Druey KM. Heterotrimeric G protein signal-
Hughes JF (see Jerrim et al). 2002:109:63-7 ing: role in asthma and allergic inflammation
Hugo S (see Reich et al). 2002:109:68 1 2002: 109:592-602
Hultsch T (see Kuehr et al). 2002:109:274-80 Jones CA, Holloway JA, Popplewell EJ, Diaper ND, Hol-
Hurme M (see Karjalainen et al). 2002:109:514-6 loway JW, Vance GHS, Warner JA, Warner JO
(Brief communication) Reduced soluble CDI4 levels in amniotic fluid and
Huszar E (see Vizi et al). 2002:109:446-8 breast milk are associated with the subsequent develop-
(Brief communication) ment of atopy, eczema, or both. 2002; 109:858-66
Hwang JB (see Chung et al). 2002:109: 150-4 Joos L (see Brutsche et al). 2002;109:271-3
Joshi P. Mofidi S, Sicherer SH. Interpretation of commer-
cial food ingredient labels by parents of food-allergic
lacovacci P( see Tinghinoe t al). 2002:109:314-20 children. 2002:109:1019-21
J ALLERGY CLIN IMMUNOL Author index 1049
VOLUME 109, NUMBER 6
Jousilahti P (see Vartiainen et al). 2002;109:643-8 not with atopy and nonspecific bronchial hyperrespon-
Juarez C (see Posadas et al). 2002;109:155-61 siveness. 2002;109:630-5
Judodihardjo H (see Reitamo et al). 2002;109:547-55 Kim SG (see Chung et al). 2002;109:150-4
Jiinger M (see Reitamo et al). 2002;109:539-46 Kim Y-K (see Kim et al). 2002;109:630-5
Kim Y-Y (see Kim et al). 2002;109:630-5
K Kimpen JLL (see Schade et al). 2002;109:357-62
Kalimo K (see Reitamo et al). 2002;109:539-46, 547-55 Kinaciyan T (see Untersmayr et al). 2002;109:1034-5
Kalliomaki M (see Rautava et al). 2002;109:119-21 (Letters to the editor)
(Brief communication) Kinaciyan T, Natter S, Kraft D, Sting] G, Valenta R. IgE
Kamin W (see Kuehr et al). 2002;109:274-80 autoantibodies monitored in a patient with atopic der-
Kanani A (see Saary et al). 2002;109:131-5 matitis under cyclosporin A treatment reflect tissue
Kaneko H (see Watanabe et al). 2002; 109:669-75 damage. 2002;109:717-9 (Letters to the editor)
Kaplan AP (see Kikuchi and Kaplan). 2002;109:114-8 King TS (see Szefler et al). 2002;109:410-8
Kaplan AP (see Ying et al). 2002; 109:694-700 (Rapid publications)
Kaplan AP, Kusumam J, Silverberg M. Pathways for Kino T, Chrousos GP. Tissue-specific glucocorticoid resis-
bradykinin formation and inflammatory disease. tance-hypersensitivity syndromes: multifactorial states
2002; 109: 195-209 of clinical importance. 2002;109:609-13
Kapp A (see Guizmer et al). 2002;109:524-31 Kircher MF, Haeusler T, Nickel R, Lamb JR, Renz H,
Kapp A (see Wedi et al). 2002;109:477-84 Beyer K. VB18.1+ and Va2.3+ T-cell subsets are associ-
Karim MY, Masood A. Fresh-frozen plasma as a treatment ated with house dust mite allergy in human subjects.
for life-threatening ACE-inhibitor angioedema. 2002;109:517-23
2002; 109:370-1 (Letters to the editor) Klaukka T (see Karjalainen et al). 2002;109:514-6
Karjalainen J, Nieminen MM, Aromaa A, Klaukka T, (Brief communication)
Hurme M. The IL-18 genotype carries asthma suscepti- Klontz KC (see Vierk et al). 2002; 109: 1022-6
bility only in men. 2002;109:514-6 Knol EF (see Schade et al). 2002;109:357-62
(Brief communication) Kobayashi M (see Kawagishi et al). 2002;109:936-42
Karlsson O (see Dahlén et al). 2002;109:789-93 Koester J (see Baramki et al). 2002;109:449-54
Karnani R (see Kudva-Patel et al). 2002;109:888-9 Koh YI, Choi IS, Lee S-H, Lee J-B, Park C-H, Hong S-N.
(Letters to the editor) Localized heat urticaria associated with mast cell and
Kasahara K (see Watanabe et al). 2002;109:669-75 eosinophil degranulation. 2002;109:714-5
Kasche A (see Traidl-Hoffmann et al). 2002;109:831-8 (Letters to the editor)
Kashii T (see Kawagishi et al). 2002;109:936-42 Koivikko A (see Mller et al). 2002;109:251-6
Kastner M (see Hoff et al). 2002;109:96-101 Kollai M (see Vizi et al). 2002;109:446-8
Kato Z (see Watanabe et al). 2002;109:669-75 (Brief communication)
Kauffman HF (see Koppelman et al). 2002;109:498-506 Koller DY (see Mller et al). 2002;109:251-6
Kawabata T (see Adkinson et al). 2002;109:S461-S478 Kondo N (see Watanabe et al). 2002;109:669-75
Kawagishi Y, Mita H, Taniguchi M, Maruyama M, Oosaki Kondo T (see Watanabe et al). 2002;109:669-75
R, Higashi N, Kashii T, Kobayashi M, Akiyama K. Koppelman GH, Stine OC, Xu J, Howard TD, Zheng SL,
Leukotriene C, synthase promoter polymorphism in Kauffman HF, Bleecker ER, Meyers DA, Postma DS.
Japanese patients with aspirin-induced asthma. Genome-wide search for atopy susceptibility genes in
2002; 109:936-42 Dutch families with asthma. 2002;109:498-506
Kawakubo Y (see Sieben et al). 2002;109:1005-11 Kraft D (see Kinaciyan et al). 2002;109:717-9
Kay AB (see Ying et al). 2002;109:694-700 (Letters to the editor)
Keen J (see Valapour et al). 2002;109:238-45 Kraft M (see Szefler et al). 2002;109:410-8
(Rapid publications) (Rapid publications)
Kelly HW (see Stempel and Kelly). 2002;109:S503-S510 Krail M (see Hoff et al). 2002;109:96-101
Kelsen SG (see Aksoy et al). 2002;109:491-7 Krishna MT (see Polosa et al). 2002;109:75-81
Kennedy G (see Dempsey et al). 2002;109:68-74 Kriiger K (see Trautmann et al). 2002;109:329-37
Kesavan J (see Phipatanakul et al). 2002;109:794-9 Kudo K (see Yoshimura et al). 2002;109:817-23
Kikuchi Y (see Ying et al). 2002;109:694-700 Kudva-Patel V, White E, Karnani R, Collins MH, Assa’ad
Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG- AH. Drug reaction to ceftriaxone in a child with X-
dependent histamine release from basophils in chronic linked agammaglobulinemia. 2002;109:888-9
urticaria. 2002;109:114-8 (Letters to the editor)
Kiley J (see Szefler et al). 2002;109:410-8 Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Von
(Rapid publications) Berg A, Leupold W, Bergmann K-C, Rolinck-Werning-
Kim H-H (see Schroeder et al). 2002;109:507-13 haus C, Griive M, Hultsch T, Wahn U. Efficacy of com-
Kim S-H, Oh S-Y, Oh H-B, Kim Y-K, Cho S-H, Kim Y-Y, bination treatment with anti-IgE plus specific
Min K-U. Association of B-adrenoreceptor polymor- immunotherapy in polysensitized children and adoles-
phisms with nocturnal cough among atopic subjects but cents with seasonal allergic rhinitis. 2002; 109:274-80
1050 Author index J ALLERGY CLIN IMMUNOL
JUNE 2002
Kuna P (see Stelmach et al). 2002;109:257-63 Lilly CM, Churg A, Lazarovich M, Pauwels R, Hendeles L,
Kunisaki J-I (see He et al). 2002;109:1035-6 Rosenwasser LJ, Ledford D, Wechsler ME. Asthma ther-
(Letters to the editor) apies and Churg-Strauss syndrome. 2002;109:S1-S19
Kusumam J (see Kaplan et al). 2002;109: 195-209 Lin XP, Magnusson J, Ahlstedt S, Dahlman-Héglund A,
Hanson LA, Magnusson O, Bengtsson U, Telemo E.
L Local allergic reaction in food-hypersensitive adults
a Grutta S (see Pajno and La Grutta). 2002; 109:890 despite a lack of systemic food-specific IgE.
(Correspondence) 2002; 109:879-87
a Grutta S (see Pajno et al). 2002:109:627-9 Lipworth BJ (see Dempsey et al). 2/2; 109:68-74
(Brief communication) Lipworth BJ (see Fowler et al). 2002; 109:929-35
Salla A (see Idzko et al). 2002:109:839-46 Lisewski M (see Gutzmer et al). 2002;109:524-31
ack G (see Taylor et al). 2002;109:24-30 (Rostrum) Liu AH. Endotoxin exposure in allergy and asthma: recon-
acy P (see Logan et al). 2002;109:299-306 ciling a paradox. 2002; 109:379-92
ahfa M (see Reitamo et al). 2002:109:547-55 Logan MR, Lacy P, Bablitz B, Mogbel R. Expression of
ahn M (see Tomkinson et al). 2002;109:810-6 eosinophil target SNAREs as potential cognate recep-
amb JR (see Bhatia et al). 2002;109:321-8 tors for vesicle-associated membrane protein-2 in exo-
amb JR (see Kircher et al). 2002;109:517-23 cytosis. 2002;109:299-306
andi L (see Zanconato et al). 2002;109:440-5 Loke T-K (see Hawrylowicz et al). 2002;109:369
ange B (see Bachert et al). 2002;109:573-4 (Letters to the editor)
(Letters to the editor) Létvall J (see Pullerits et al). 2002;109:949-55
anger K (see Gutzmer et al). 2002;109:524-31 Léwhagen O (see Arvidsson et al). 2002;109:777-83
aouini D (see Alenius et al). 2002:109: 106-13 Lugg DJ (see Shearer et al). 2002;109:854-7
arbanois A (see Vandenplas et al). 2002;109:125-3( (Brief communication)
arsen E (see Santeliz et al). 2002;109:455-62 Lukat K-F (see Bachert et al). 2002;109:573-4
auwers-Cancés V (see Rancé et al). 2002:109:1027-33 (Letters to the editor)
avigne S (see Davoine et al). 2002;109:463-9 Lumme A (see Helenius et al). 2002;109:962-8
aviolette M (see Davoine et al). 2002;109:463-9 Lundahl J (see Upham et al). 2002;109:307-13
ayton TA (see Weiler et al). 2002;109:995-1000 Liittkopf D (see Pastorello et al). 2002;109:563-70
azarovich M (see Lilly et al). 2002;109:S1-S19 Izumi S (see Yoshimura et al). 2002;109:817-23
azarus SC (see Szefler et al). 2002;:109:410-8
(Rapid publications) M
edford D (see Lilly et al). 2002;109:S1-S19 Maghni K (see Suzuki et al). 2002;109:803-9
ee B-N (see Shearer et al). 2002;109:854-7 Magnusson J (see Lin et al). 2002;109:879-87
(Brief communication) Magnusson O (see Lin et al). 2002;109:879-87
ee J-B (see Koh et al). 2002;109:714-5 Mahmic A (see Mitakakis et al). 2002;109:122-4
(Letters to the editor) (Brief communication)
ee S-H (see Koh et al). 2002:109:714-5 Malmberg H (see Rinne et al). 2002;109:426-32
(Letters to the editor) Mao X-Q (see Arima et al). 2002:109:980-7
ee T (see Hawrylowicz et al). 2002;109:369 Mapp CE, Fryer AA, De Marzo N, Pozzato V, Padoan M,
(Letters to the editor) Boschetto P, Strange RC, Hemmingsen A, Spiteri MA.
emanske RF Jr (see Szefler et al). 2002:109:410-8 Glutathione S-transferase GSTP/ 1s a susceptibility
(Rapid publications) gene for occupational asthma induced by isocyanates.
emanske RF Jr. Issues in understanding pediatric asthma 2002: 109:867-72
epidemiology and genetics. 2002;109:S521-S524 Mardini IA (see Aksoy et al). 2002;109:491
euba F (see Zarei et al). 2002;109:988-94 Mari A (see Tinghino et al). 2002;109:314-20
eung DYM, Hopper N. Learning from the past and look Mariani V (see Mascia et al). 2002;109:532-8
ing to the future. 2002;109:22-3 (Editorial) Martin JG (see Suzuki et al). 2002;109:803-9
eung DYM, Nelson HS, Szefler S. The editors’ choice Martin RJ (see Szefler et al). 2002;109:410-8
2002;109:1-2, 187-8, 377-8, 579-80, 745-6, 893-4 (Rapid publications)
Leupold W (see Kuehr et al). 2002;109:274-80 Martin RJ. Therapeutic significance of distal airway
evitt RC (see Toda et al). 2002: 109:246-50 inflammation in asthma. 2002;109:S477-S460
(Rapid publications) Martin S (see Basomba et al). 2002;109:943-8
ewis SA (see Broadfield et al). 2002;109:969-74 Martinez FD (see Guerra et al). 2002:109:419-25
ewis SA (see McKeever et al). 2002;109:43-50 Maruyama M (see Kawagishi et al). 2002;109:936-42
(Rapid publications), 800-2 (Brief communication) Maryska S (see Raulf-Heimsoth et al). 2002;109:715-6
eyva L (see Posadas et al). 2002:109:155-61 (Letters to the editor)
i X-M, Sampson HA. Glucocorticoids in herbal formu Masaoudi TA (see Sieben et al). 2002:109: 1005-1 1
las? 2002; 109: 1038 (Letter reply) Mascarenhas M (see Spergel et al). 2002;109:363-8
Liacouras CA (see Spergel et al). 2002;109:363-8 Mascia F, Mariani V, Giannetti A, Girolomoni G, Pastore
J ALLERGY CLIN IMMUNOL Author index 1051
VOLUME 109, NUMBER 6
S. House dust mite allergen exerts no direct proinflam- Mommert S (see Gutzmer et al). 2002;109:524-31
matory effects on human keratinocytes. 2002;109:532-8 Moneret-Vautrin DA (see Taylor et al). 2002; 109:24-30
Masood A (see Karim and Masood). 2002;109:370-1 (Rostrum)
(Letters to the editor) Montuschi P, Barnes PJ. Exhaled leukotrienes and
Mastalerz L (see Szczeklik et al). 2002;109:572-3 prostaglandins in asthma. 2002;109:615-20
(Letters to the editor) Mogbel R (see Logan et al). 2002;109:299-306
Matsui E (see Watanabe et al). 2002;109:669-75 Morita H (see He et al). 2002; 109: 1035-6 (Letters to the editor)
Matsumoto K, Gauvreau GM, Rerecich T, Watson RM, Morris SC (see Strait et al). 2002;109:658-68
Wood LJ, O’ Byrne PM. IL-10 production in circulating Mukhopadhyay S (see Bhatia et al). 2002;109:321-8
T cells differs between allergen-induced isolated early Mullol J, Fernandez-Morata JC, Roca-Ferrer J, Pujols L,
and dual asthmatic responders. 2002;109:281-6 Xaubet A, Benitez P, Picado C. Cyclooxygenase I and
Matsuo H (see Tanaka et al). 2002;109:485-90 cyclooxygenase 2 expression is abnormally regulated in
Matthews JG (see Irusen et al). 2002;109:649-57 human nasal polyps. 2002;109:824-30
Mauger E (see Szefler et al). 2002;109:410-8
(Rapid publications) N
Maves KK (see Weiler et al). 2002;109:995-1000 Nagase H (see Yoshimura et al). 2002;109:817-23
Mayorga C (see Posadas et al). 2002;109:155-61 Nagata M, Saito K, Tsuchiya K, Sakamoto Y. Leukotriene
McKechnie MT (see Jerrim et al). 2002;109:63-7 D, upregulates eosinophil adhesion via the cysteiny]
McKeever TM (see Broadfield et al). 2002;109:969-74 leukotriene | receptor. 2002;109:676-80
McKeever TM, Lewis SA, Sinith C, Collins J, Heatlie H, Napoli DC (see Tankersley et al). 2002;109:556-62
Frischer M, Hubbard R. Early exposure to infections Natter S (see Kinaciyan et al). 2002;109:717-9
and antibiotics and the incidence of allergic disease: a (Letters to the editor)
birth cohort study with the West Midlands General Naya I (see Dahlén et al). 2002;109:789-93
Practice Research Database. 2002;109:43-50 Nel AE, Slaughter N. T-cell activation through the antigen
(Rapid publications) receptor. Part 2: role of signaling cascades in T-cell dif-
McKeever TM, Lewis SA, Smith C, Hubbard R. Mode of ferentiation, anergy, immune senescence, and develop-
delivery and risk of developing allergic disease. ment of immunotherapy. 2002;109:901-15
2002; 109:800-2 (Brief communication) Nel AE. T-cell activation through the antigen recepior. Part
Meng Q (see Ying et al). 2002;109:694-700 1: signaling components, signaling pathways, and sig-
Merk HF (see Sieben et al). 2002;109: 1005-11 nal integration at the T-cell antigen receptor synapse.
Metcalfe DD (see Brockow et al). 2002;109:82-8 2002; 109:758-70
Metcalfe DD (see Devouassoux et al). 2002;109:847-53 Nelson HS (see Leung et al). 2002;109:1-2, 187-8, 377-8,
Metcalfe DD (see Foster et al). 2002;109:287-93 579-80, 745-6, 893-4
Metcalfe DD (see Taylor et al). 2002;109:24-30 (Rostrum) Neslusan C (see Crystal-Peters et al). 2002;109:57-62
Meyer JW (see Stempel et al). 2002;109:433-9 Nest GV (see Santeliz et al). 2002;109:455-62
Meyer RJ (see Chowdhury and Meyer). 2002;109:720 Neumann C (see Reich et al). 2002;109:681-7
(Correspondence) Neves N (see Carvalho et al). 2002;109:102-5
Meyers DA (see Koppelman et al). 2002;109:498-506 Nickel R (see Kircher et al). 2002;109:517-23
Middel P (see Reich et al). 2002;109:68 1-7 Nickolls PM (see Shearer et al). 2002;109:854-7
Min K-U (see Kim et al). 2002;109:630-5 (Brief communication)
Minoguchi K (see Tanaka et al). 2002;109:485-90 Nieminen MM (see Karjalainen et al). 2002;109:514-6
Mistrello G (see Asero et al). 2002;109:371-2 (Brief communication)
(Letters to the editor) Niggemann B (see Moller et al). 2002;109:215- 6
Mita H (see Kawagishi et al). 2002;109:936-42 Nizankowska E (see Szczeklik et al). 2002;109:572-3
Mitakakis TZ, Mahmic A, Educ GD, Tovey ER. Compari- (Letters to the editor)
son of vacuuming procedures for reservoir dust mite Norberg LA (see Miller et al). 2002;109:251-6
allergen on carpeted floors. 2002;109:122-4 Norgauer J (see Idzko et al). 2002; 199:839-46
(Brief communication) Nowak-Wegrzyn A (see Phipatanakul et al). 2002;109:794-9
Miura K (see Schroeder et al). 2002;109:507-13
Mizoguchi E (see Alenius et al). 2002;109:106-13 oO
Mockenhaupt M (see Idzko et al). 2002;109:839-46 O’ Byrne PM (see Dahlén et al). 2002;109:789-93
Mofidi S (see Joshi P et al). 2002;109:1019-21 O’ Byrne PM (see Matsumoto et al). 2002;109:281-6
Molet S (see Suzuki et al). 2002;109:803-9 O’ Byrne PM, Inman MD, Parameswaran K. The trials and
Miiler C, Dreborg S, Ferdousi HA, Halken S, H@st A, tribulations of anti-IL-5 . . . 2002;109:575-6 (Letter reply)
Jacobsen L, Koivikko A, Koller DY, Niggemann B, O'Donnell JC (see Stempel et al). 2002;109:433-9
Norberg LA, Urbanek R, Valovirta E, Wahn U. Pollen O’ Dowd L, Thorsson L, Edsbacker S. Systemic availability
immunotherapy reduces the development of asthma in of Rhinocort Aqua (budesonide) nasal spray: impor-
children with seasonal rhinoconjunctivitis (the PAT- tance of formulation and definition of delivered dose.
study). 2002;109:251-6 2002;109:1037 (Correspondence)
1052 Author index J ALLERGY CLIN IMMUNOL
JUNE 2002
O'Meara TJ (see Poulos et al). 2002;109:701-6 cacy of montelukast in the treatment of cat allergen—
Oda N (see Tanaka et al). 2002; 109:485-90 induced asthma in children. 2002;109:794-9
Oettgen HC (see Alenius et al). 2002;109: 106-13 Picado C (see Mullol et al). 2002;109:824-30
Oh H-B (see Kim et al). 2002;109:630-5 Piguet V (see Zarei et al). 2002;109:988-94
Oh S-Y (see Kim et al). 2002;109:630-5 Piipari R (see Jaakkola et al). 2002;109:784-8
Okada S (see Tanaka et al). 2002;109:485-90 Pini C (see Tinghino et al). 2002:109:314-20
Olaguibel JM (see Basomba et al). 2002;109:943-8 Pittman N (see Beyer et al). 2002;109:707-13
Olinsky A (see Phelan et al). 2002;109:189-94 Plitt J (see Aizawa et al). 2002;109:176
Ono T (see Shiota et al). 2002;109:294-8 (Letters to the editor)
Oosaki R (see Kawagishi et al). 2002;109:936-42 Plétz S (see Traidl-Hoffmann et al). 2002;109:831-8
Ortolani C (see Pastorello et al). 2002;109:563-70 Polo F (see Quirce et al). 2002;109:178
Oude Elberink JNG, de Monchy JGR, Golden DBK, (Letters to the editor)
Brouwer J-LP, Guyatt GH, Dubois AEJ. Development Polosa R, Puddicombe SM, Krishna MT, Tuck AB,
and validation of a health-related quality-of-life ques- Howarth PH, Holgate ST, Davies DE. Expression of c-
tionnaire in patients with yellow jacket allergy. erbB receptors and ligands in the bronchial epithelium
2002; 109: 162-70 of asthmatic subjects. 2002:109:75-81
Ouwehand AC (see He et al). 2002; 109: 1035-6 (Letters to Popplewell EJ (see Jones et al). 2002;109:858-66
the editor) Posadas SJ, Padial A, Torres MJ, Mayorga C, Leyva L,
Sanchez E, Alvarez J, Romano A, Juarez C, Blanca M.
P
Delayed reactions to drugs show levels of perforin,
Padial A (see Posadas et al). 2002;109:155-61 granzyme B, and Fas-L to be related to disease severity.
Padoan M (see Mapp et al). 2002;109:867-72 2002; 109:155-61
Pajno GB, La Grutta S, Barberio G, Canonica GW, Pas- Postma DS (see Koppelman et al). 2002;109:498-506
salacqua G. Harmful effect of immunotherapy in chil- Poulos LM, O'Meara TJ, Hamilton RG, Tovey ER. Inhaled
dren with combined snail and mite allergy latex allergen (Hev b 1). 2002;109:701-6
2002; 109:627-9 (Brief communication) Poulsen LK (see Pastorello et al). 2002:109:563-70
Pajno GB, La Grutta S. Allergy to Parietaria pollen and Poulsen LK (see Untersmayr et al). 2002;109: 1034-5
the ETAC study. 2002;109:890 (Correspondence) (Letters to the editor)
Panther E (see Idzko et al). 2002;109-839-46 Pozzato V (see Mapp et al). 2002;109:867-72
Parameswaran K (see O’ Byrne et al). 2002;109:575-6 Praks L (see Pullerits et al). 2002;109:949-55
(Letter reply) Pravettoni V (see Pastorello et al). 2002:109:563-70
Park C-H (see Koh et al). 2002;109:714-5 Prussin C (see Devouassoux et al). 2002;109:847-53
(Letters to the editor) Prussin C (see Foster et al). 2002;109:287-93
Park H-S, Frew AJ. Genetic markers for occupational asth- Puddicombe SM (see Polosa et al). 2002;109:75-81
ma. 2002;109:774-6 (Editorial) Puggioni EMR (see Tinghino et al). 2002;109:314-20
Park JJ (see Chung et al). 2002;109:150-4 Pujols L (see Mullol et al). 2002:109:824-30
Passalacqua G (see Pajno et al). 2002:109:627-9 Pullerits T, Praks L, Ristioja V, Létvall J. Comparison of a
(Brief communication) nasal glucocorticoid, antileukotriene, and a combination
Pastore S (see Mascia et al). 2002;109:532-8 of antileukotriene and antihistamine in the treatment of
Pastorello EA, Vieths S, Pravettoni V, Farioli L, Trambaioli seasonal allergic rhinitis. 2002;109:949-55
C, Fortunato D, Liittkopf D, Calamari M, Ansaloni R, Purdham J (see Tarlo and Purdham). 2002:109:603-5
Scibilia J, Ballmer-Weber BK, Poulsen LK, Wiitrich B, (Editorial)
Hansen KS, Robino AM, Ortolani C, Conti A. Identifi- Puri RK (see Arima et al). 2002;109:980-7
cation of hazelnut major allergens in sensitive patients
with positive double-blind, placebo-controlled food Q
challenge results. 2002;109:563-70 Qu X-W (see Strait et al). 2002:;109:658-68
Pauwels R (see Lilly et al). 2002;109:S1-S19 Quinn SA (see Weiler et al). 2002;109:995-1000
Pauwels RA (see Rizzo et al). 2002;109:404-9 Quirce S, Fernandez-Nieto M, Polo F, Sastre J. Soybean
(Rapid publications) trypsin inhibitor is an occupational inhalant allergen
Pekkanen J (see Vartiainen et al). 2002;109:643-8 2002:;109:178 (Letters to the editor)
Penrose JF (see Bandeira-Melo et al). 2002;109:975-9
Petiays T (see Vartiainen et al). 2002; 109:643-8 R
Peters SP (see Szefler et al). 2002;109:410-8 Ra C (see Yoshimura et al). 2002;109:817-23
(Rapid publications) Rabe KF (see ten Brinke et al). 2002;109:621-6
Pfrommer C (see Zuberbier et al). 2002; 109:343-8 Rak S (see Arvidsson et al). 2002;109:777-83
Phelan PD, Robertson CF, Olinsky A. The Melbourne Rakoski J (see Grimm et al). 2002:109:370
Asthma Study: 1964-1999. 2002;109:189-94 (Letters to the editor)
Phipatanakul W, Nowak-Wegrzyn A, Egg'eston PA, Van Rance F (see Taylor et al). 2002;109:24-30 (Rostrum)
Natta M, Kesavan J, Schuberth K, Wood RA. The effi- Rancé F, Abbal M, Lauwers-Cancés V. Improved screening